Skip to main content
TipRanks
Go Ultimate75% OFF

Pacira Pharmaceuticals (82P) Q4 2023 Earnings Report

0 Followers

DE:82P Q4 2023 EPS Results

Actual EPS
EUR 0.80
Consensus EPS
EUR 0.79
Beat/Miss
Beat by +EUR 0.01
One Year Ago EPS
EUR 0.72

DE:82P Q4 2023 Revenue Results

Actual Revenue
EUR 162.28M
Expected Revenue
EUR 161.72M
Beat/Miss
Beat by +EUR 558.70K
YoY Revenue Growth
+5.40%

Earnings Announcement Details

Quarter
Q4 2023
Date
02/29/2024
Time
Before Open
Conference Call
Thursday, February 29, 2024
DE:82P Upcoming Earnings

Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

DE:82P Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:82P Earnings History

DE:82P earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)―-0.51――
Oct 29, 20262026 (Q3)0.670.620.63-0.29% (-0.00)
Aug 04, 20262026 (Q2)0.580.650.66-1.35% (-0.01)
Apr 30, 20262026 (Q1)0.490.540.56-3.23% (-0.02)
Feb 26, 20262025 (Q4)0.810.510.81-37.36% (-0.30)
Nov 06, 20252025 (Q3)0.610.630.71-11.39% (-0.08)
Aug 05, 20252025 (Q2)0.640.660.8-16.85% (-0.13)
May 08, 20252025 (Q1)0.530.560.560.00% (+0.00)
Feb 27, 20252024 (Q4)0.750.810.82.25% (+0.02)
Nov 06, 20242024 (Q3)0.630.710.649.72% (+0.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed